S
Stefano Fagiuoli
Researcher at University of Padua
Publications - 354
Citations - 10067
Stefano Fagiuoli is an academic researcher from University of Padua. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 46, co-authored 308 publications receiving 8386 citations. Previous affiliations of Stefano Fagiuoli include The Catholic University of America & United States Code.
Papers
More filters
Journal ArticleDOI
Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: A retrospective study
S. Bruno,Tommaso Stroffolini,Massimo Colombo,Simona Bollani,Luisa Benvegnù,Giuseppe Mazzella,Antonio Ascione,Teresa Santantonio,Felice Piccinino,Pietro Andreone,Alessandra Mangia,Giovanni Battista Gaeta,Marcello Persico,Stefano Fagiuoli,Piero Luigi Almasio +14 more
TL;DR: In patients with HCV‐related, histologically proven cirrhosis, achievement of a SVR after IFNα therapy was associated with a reduction of liver‐related mortality lowering both the risk of complications and HCC development.
Journal ArticleDOI
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma.
Umberto Cillo,Alessandro Vitale,Marco Bassanello,Patrizia Boccagni,Alberto Brolese,Giacomo Zanus,Patrizia Burra,Stefano Fagiuoli,Fabio Farinati,Massimo Rugge,Davide F. D'Amico +10 more
TL;DR: The routine pre-orthotopic liver transplantation tumor grading may represent a valid tool in the selection of unresectable HCC patients for transplantation.
Journal ArticleDOI
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
Paolo Caraceni,Oliviero Riggio,Paolo Angeli,Carlo Alessandria,Sergio Neri,Francesco Giuseppe Foschi,F. Levantesi,Aldo Airoldi,S. Boccia,Gianluca Svegliati-Baroni,Stefano Fagiuoli,Roberto Giulio Romanelli,Raffaele Cozzolongo,Vito Di Marco,Vincenzo Sangiovanni,Filomena Morisco,Pierluigi Toniutto,Annalisa Tortora,Rosanna De Marco,Mario Angelico,Irene Cacciola,Gianfranco Elia,Alessandro Federico,Sara Massironi,Riccardo Guarisco,Alessandra Galioto,Giorgio Ballardini,Maria Rendina,Silvia Nardelli,Salvatore Piano,Chiara Elia,Loredana Prestianni,Federica Mirici Cappa,Lucia Cesarini,L. Simone,Chiara Pasquale,M. Cavallin,Alida Andrealli,F. Fidone,Matteo Ruggeri,A. Roncadori,Maurizio Baldassarre,Manuel Tufoni,Giacomo Zaccherini,Mauro Bernardi,Marco Domenicali,Ferdinando Giannone,Manuela Merli,Stefania Gioia,Silvano Fasolato,Antonietta Sticca,Daniela Campion,A. Risso,Giorgio Maria Saracco,D. Maiorca,Agostino Rizzotto,Arianna Lanzi,Elga Neri,Anna Visani,Antonio Mastroianni,A Alberti,Chiara Mazzarelli,Marcello Vangeli,Marco Marzioni,Francesca Capretti,Alba Kostandini,G. Magini,M. Colpani,Giacomo Laffi,T Gabbani,Maria Marsico,M. Zappimbulso,Josè Petruzzi,Vincenza Calvaruso,Giovanni Parrella,Nicola Caporaso,Francesco Auriemma,Maria Guarino,Fabio Pugliese,Antonio Gasbarrini,Pietro Leo,Francesco De Leonardis,A. Pecchioli,Piera Rossi,Giovanni Raimondo,Elisa Negri,Marcello Dallio,Carmelina Loguercio,Dario Conte,Natascia Celli,R. Bringiotti,N.M. Castellaneta,Francesco Salerno +92 more
TL;DR: Long-term HA administration prolongs overall survival and might act as a disease modifying treatment in patients with decompensated cirrhosis in this trial.
Journal ArticleDOI
Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features.
Silvano Fasolato,Paolo Angeli,Lucia Dallagnese,Giulio Maresio,Erika Zola,Elena Mazza,F. Salinas,Silvio Donà,Stefano Fagiuoli,Antonietta Sticca,Giacomo Zanus,Umberto Cillo,Ilaria Frasson,C. Destro,Angelo Gatta +14 more
TL;DR: The results of the study show that the development of bacterial‐induced renal failure in patients with cirrhosis and ascites is related to the MELD score, and to both the severity and the lack of resolution of the infection.
Journal ArticleDOI
Gut microbiota in autism and mood disorders
Francesca Mangiola,Gianluca Ianiro,Francesco Franceschi,Stefano Fagiuoli,Giovanni Gasbarrini,Antonio Gasbarrini +5 more
TL;DR: A deeper assessment of the role of gut microbiota in the development of autism spectrum disorder (ASD), as well as the advancement of the therapeutic armamentarium for the modulation of Gut microbiota is warranted for a better management of ASD and mood disorders.